Forbes Ranks Highest R&D Costs of 100 Pharma Companies

Source: PharmaManufacturing.com

Aug 12, 2013

Forbes

Companies that invent more drugs at a lower cost do better than those that hemorrhage cash but never get an important product to market. Yet 19 in 20 medicines in experimental development fail, meaning a great many companies fail, too. Read the full story